| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R44NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 7 | NIH | 11/10/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $965,517 ) |
| | 2019 | 2019 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R44NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 7 | NIH | 4/30/2019 | $965,517 |
|
| Issue Date FY: 2018 ( Subtotal = $965,515 ) |
| | 2018 | 2018 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R44NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 6 | NIH | 6/25/2018 | $965,515 |
| | 2018 | 2016 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R44NS090629 | Development of a Neurotensin Fragment for Neuropathic Pain | 000 | 2 | NIH | 1/23/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $965,517 ) |
| | 2017 | 2017 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R44NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 5 | NIH | 8/7/2017 | $965,517 |
| | 2017 | 2016 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R42NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 4 | NIH | 8/21/2017 | $0 |
| | 2017 | 2014 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464-5641 | CHARLESTON | USA | R43DE025162 | Engineered Neurotensin Fragments Targeting Neuropathic Pain | 000 | 1 | NIH | 2/9/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,305,782 ) |
| | 2016 | 2016 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R44NS090629 | Development of a Neurotensin Fragment for Neuropathic Pain | 000 | 2 | NIH | 4/18/2016 | $599,575 |
| | 2016 | 2016 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R42NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 4 | NIH | 7/14/2016 | $706,207 |
| | 2016 | 2014 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 294645641-5641 | CHARLESTON | USA | R43DE025162 | Engineered Neurotensin Fragments Targeting Neuropathic Pain | 000 | 1 | NIH | 2/19/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $1,666,346 ) |
| | 2015 | 2015 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R42NS073378 | Stroke Treatment by Chemically-induced Hypothermia | 000 | 3 | NIH | 4/24/2015 | $793,793 |
| | 2015 | 2015 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R44NS090629 | Development of a Neurotensin Fragment for Neuropathic Pain | 000 | 1 | NIH | 2/17/2015 | $647,660 |
| | 2015 | 2014 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R43DA036398 | Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonists for Peripheral Pain | 001 | 2 | NIH | 1/15/2015 | $224,893 |
|
| Issue Date FY: 2014 ( Subtotal = $324,258 ) |
| | 2014 | 2014 | JT PHARMACEUTICALS, INC. | 300 W COLEMAN BLVD STE 203 | MOUNT PLEASANT | SC | 29464 | CHARLESTON | USA | R43DE025162 | Engineered Neurotensin Fragments Targeting Neuropathic Pain | 000 | 1 | NIH | 9/23/2014 | $324,258 |
|
|
